{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T08:27:36Z","timestamp":1793608056857,"version":"4.5.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T00:00:00Z","timestamp":1720656000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["EDDPGM-Nov22\/100004"],"award-info":[{"award-number":["EDDPGM-Nov22\/100004"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020013","name":"NIHR Leicester Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["FDN-148390"],"award-info":[{"award-number":["FDN-148390"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019434","name":"NIHR Exeter Clinical Research Facility","doi-asserted-by":"publisher","award":["NIHR203320"],"award-info":[{"award-number":["NIHR203320"]}],"id":[{"id":"10.13039\/501100019434","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018956","name":"NIHR Cambridge Biomedical Research Centre","doi-asserted-by":"publisher","award":["NIHR203312"],"award-info":[{"award-number":["NIHR203312"]}],"id":[{"id":"10.13039\/501100018956","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["annalsofoncology.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.annonc.2024.07.244","type":"journal-article","created":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T12:33:53Z","timestamp":1720442033000},"page":"892-901","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Population-based germline breast cancer gene association studies and meta-analysis to inform wider mainstream testing"],"prefix":"10.1016","volume":"35","author":[{"given":"C.F.","family":"Rowlands","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Balma\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.M.","family":"Domchek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.G.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Hanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Hoogerbrugge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.A.","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.L.","family":"Nathanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Robson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Tischkowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.D.","family":"Foulkes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Turnbull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5182","key":"10.1016\/j.annonc.2024.07.244_bib1","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1126\/science.7545954","article-title":"A\u00a0strong candidate for the breast and ovarian cancer susceptibility gene BRCA1","volume":"266","author":"Miki","year":"1994","journal-title":"Science"},{"issue":"6559","key":"10.1016\/j.annonc.2024.07.244_bib2","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/378789a0","article-title":"Identification of the breast cancer susceptibility gene BRCA2","volume":"378","author":"Wooster","year":"1995","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.annonc.2024.07.244_bib3","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/ng.893","article-title":"Germline mutations in RAD51D confer susceptibility to ovarian cancer","volume":"43","author":"Loveday","year":"2011","journal-title":"Nat Genet"},{"issue":"5","key":"10.1016\/j.annonc.2024.07.244_bib4","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/ng.2224","article-title":"Germline RAD51C mutations confer susceptibility to ovarian cancer","volume":"44","author":"Loveday","year":"2012","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.annonc.2024.07.244_bib5","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/ng1959","article-title":"PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene","volume":"39","author":"Rahman","year":"2007","journal-title":"Nat Genet"},{"issue":"7133","key":"10.1016\/j.annonc.2024.07.244_bib6","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/nature05609","article-title":"A\u00a0recurrent mutation in PALB2 in Finnish cancer families","volume":"446","author":"Erkko","year":"2007","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.annonc.2024.07.244_bib7","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/ng1837","article-title":"ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles","volume":"38","author":"Renwick","year":"2006","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.annonc.2024.07.244_bib8","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/ng879","article-title":"Low-penetrance susceptibility to breast cancer due to CHEK2(\u2217)1100delC in noncarriers of BRCA1 or BRCA2 mutations","volume":"31","author":"Meijers-Heijboer","year":"2002","journal-title":"Nat Genet"},{"issue":"5","key":"10.1016\/j.annonc.2024.07.244_bib9","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1056\/NEJMoa1913948","article-title":"Breast cancer risk genes - association analysis in more than 113,000 women","volume":"384","author":"Dorling","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.annonc.2024.07.244_bib10","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1056\/NEJMoa2005936","article-title":"A\u00a0population-based study of genes\u00a0previously implicated in breast cancer","volume":"384","author":"Hu","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"7886","key":"10.1016\/j.annonc.2024.07.244_bib11","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/s41586-021-04103-z","article-title":"Exome sequencing and analysis of 454,787 UK Biobank participants","volume":"599","author":"Backman","year":"2021","journal-title":"Nature"},{"issue":"35","key":"10.1016\/j.annonc.2024.07.244_bib12","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1200\/JCO.21.00640","article-title":"Germline pathogenic variants in cancer predisposition genes among women with invasive lobular carcinoma of the breast","volume":"39","author":"Yadav","year":"2021","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.annonc.2024.07.244_bib13","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s10689-021-00241-5","article-title":"Extended gene panel testing in lobular breast cancer","volume":"21","author":"van Veen","year":"2022","journal-title":"Fam Cancer"},{"issue":"9","key":"10.1016\/j.annonc.2024.07.244_bib14","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1001\/jamaoncol.2017.0424","article-title":"Associations between cancer predisposition testing panel genes and breast cancer","volume":"3","author":"Couch","year":"2017","journal-title":"JAMA Oncol"},{"issue":"9","key":"10.1016\/j.annonc.2024.07.244_bib15","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1038\/s41588-023-01466-z","article-title":"Exome sequencing identifies breast cancer susceptibility genes and defines the contribution of coding variants to breast cancer risk","volume":"55","author":"Wilcox","year":"2023","journal-title":"Nat Genet"},{"issue":"8","key":"10.1016\/j.annonc.2024.07.244_bib16","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1093\/carcin\/bgi360","article-title":"RAD50 and NBS1 are breast cancer susceptibility genes associated with genomic instability","volume":"27","author":"Heikkinen","year":"2006","journal-title":"Carcinogenesis"},{"issue":"6","key":"10.1016\/j.annonc.2024.07.244_bib17","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/ng.3284","article-title":"Germline RECQL mutations are associated with breast cancer susceptibility","volume":"47","author":"Cybulski","year":"2015","journal-title":"Nat Genet"},{"issue":"11","key":"10.1016\/j.annonc.2024.07.244_bib18","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1002\/ijc.21738","article-title":"Evaluation of RAD50 in familial breast cancer predisposition","volume":"118","author":"Tommiska","year":"2006","journal-title":"Int J Cancer"},{"issue":"3","key":"10.1016\/j.annonc.2024.07.244_bib19","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1007\/s10549-011-1681-1","article-title":"Mutation analysis of the SLX4\/FANCP gene in hereditary breast cancer","volume":"130","author":"Landwehr","year":"2011","journal-title":"Breast Cancer Res Treat"},{"issue":"11","key":"10.1016\/j.annonc.2024.07.244_bib20","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1038\/ng1902","article-title":"Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles","volume":"38","author":"Seal","year":"2006","journal-title":"Nature Genet"},{"key":"10.1016\/j.annonc.2024.07.244_bib21","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1200\/JCO.23.02225","article-title":"Germline testing in patients with breast cancer: ASCO-Society of Surgical Oncology Guideline","volume":"42","author":"Bedrosian","year":"2024","journal-title":"J\u00a0Clin Oncol"},{"issue":"23","key":"10.1016\/j.annonc.2024.07.244_bib22","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1056\/NEJMsr1501341","article-title":"Gene-panel sequencing and the prediction of breast-cancer risk","volume":"372","author":"Easton","year":"2015","journal-title":"N\u00a0Eng J Med"},{"issue":"4","key":"10.1016\/j.annonc.2024.07.244_bib23","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1086\/374567","article-title":"Germline p53 mutations in a cohort with childhood sarcoma: sex differences in cancer risk","volume":"72","author":"Hwang","year":"2003","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.annonc.2024.07.244_bib24","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41525-018-0071-6","article-title":"Gene panel testing for breast cancer should not be used to confirm syndromic gene associations","volume":"3","author":"Evans","year":"2018","journal-title":"NPJ Genom Med"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753424010147?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753424010147?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T01:15:16Z","timestamp":1778548516000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753424010147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":24,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S0923753424010147"],"URL":"https:\/\/doi.org\/10.1016\/j.annonc.2024.07.244","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Population-based germline breast cancer gene association studies and meta-analysis to inform wider mainstream testing","name":"articletitle","label":"Article Title"},{"value":"Annals of Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annonc.2024.07.244","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd on behalf of European Society for Medical Oncology.","name":"copyright","label":"Copyright"}]}}